BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 14656542)

  • 1. Cytotoxic T lymphocyte activity and cytokine expression in calves vaccinated with formalin-inactivated bovine respiratory syncytial virus prior to challenge.
    Woolums AR; Gunther RA; McArthur-Vaughan K; Anderson ML; Omlor A; Boyle GA; Friebertshauser KE; McInturff PS; Gershwin LJ
    Comp Immunol Microbiol Infect Dis; 2004 Jan; 27(1):57-74. PubMed ID: 14656542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection.
    Antonis AF; Claassen EA; Hensen EJ; de Groot RJ; de Groot-Mijnes JD; Schrijver RS; van der Most RG
    Vaccine; 2006 Mar; 24(10):1551-61. PubMed ID: 16310293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
    Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
    J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus.
    Mapletoft JW; Oumouna M; Townsend HG; Gomis S; Babiuk LA; van Drunen Littel-van den Hurk S
    Virology; 2006 Sep; 353(2):316-23. PubMed ID: 16828832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
    Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
    Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on cytokine messenger RNA expression following viral challenge in calves.
    Miao C; Woolums AR; Zarlenga DS; Brown CC; Brown JC; Williams SM; Scott MA
    Am J Vet Res; 2004 Jun; 65(6):725-33. PubMed ID: 15198210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves.
    Gershwin LJ; Gunther RA; Anderson ML; Woolums AR; McArthur-Vaughan K; Randel KE; Boyle GA; Friebertshauser KE; McInturff PS
    Am J Vet Res; 2000 Mar; 61(3):291-8. PubMed ID: 10714521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dual vaccination for bovine respiratory syncytial virus and Haemophilus somnus on immune responses.
    Berghaus LJ; Corbeil LB; Berghaus RD; Kalina WV; Kimball RA; Gershwin LJ
    Vaccine; 2006 Aug; 24(33-34):6018-27. PubMed ID: 16777273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R; Burdett W; Roth JA
    Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bovine respiratory syncytial virus-specific immune responses in calves after inoculation with commercially available vaccines.
    Ellis JA; Hassard LE; Morley PS
    J Am Vet Med Assoc; 1995 Feb; 206(3):354-61. PubMed ID: 7751246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine responses of bovine dendritic cells and T cells following exposure to live or inactivated bovine respiratory syncytial virus.
    Werling D; Collins RA; Taylor G; Howard CJ
    J Leukoc Biol; 2002 Aug; 72(2):297-304. PubMed ID: 12149420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin-inactivated BRSV.
    Woolums AR; Singer RS; Boyle GA; Gershwin LJ
    Vaccine; 1999 Mar; 17(11-12):1293-7. PubMed ID: 10195762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology of bovine respiratory syncytial virus infection of cattle.
    Gershwin LJ
    Comp Immunol Microbiol Infect Dis; 2012 May; 35(3):253-7. PubMed ID: 22410266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination against pseudorabies virus and bovine respiratory syncytial virus infections of young animals in the face of maternally derived immunity.
    Hamers C; Juillard V; Fischer L
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S35-41. PubMed ID: 17553517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves.
    Kalina WV; Woolums AR; Gershwin LJ
    Vaccine; 2005 Aug; 23(37):4625-30. PubMed ID: 15967545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
    Kolb EA; Buterbaugh RE; Rinehart CL; Ensley D; Perry GA; Abdelsalam KW; Chase CCL
    Vaccine; 2020 Jan; 38(2):298-308. PubMed ID: 31668818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an inactivated respiratory syncytial virus vaccine in calves.
    Ellis J; West K; Konoby C; Leard T; Gallo G; Conlon J; Fitzgerald N
    J Am Vet Med Assoc; 2001 Jun; 218(12):1973-80. PubMed ID: 11417745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine respiratory syncytial virus ISCOMs--protection in the presence of maternal antibodies.
    Hägglund S; Hu KF; Larsen LE; Hakhverdyan M; Valarcher JF; Taylor G; Morein B; Belák S; Alenius S
    Vaccine; 2004 Dec; 23(5):646-55. PubMed ID: 15542185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in 3-week-old calves experimentally challenged with BRSV.
    Vangeel I; Antonis AF; Fluess M; Riegler L; Peters AR; Harmeyer SS
    Vet J; 2007 Nov; 174(3):627-35. PubMed ID: 17169592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.